Home > Browse Research > Life Sciences > Healthcare > Public Health

Public Health: market research reports

Public health is the science and practice of protecting and improving the health of a community by education, disease and injury prevention, wellness promotion, and health protection. From scientific research to health education, the field of public health strives to improve lives and social conditions that affect the health of a community. It is because of public health that we understand that second-hand smoke can cause cancer, that bicycle helmets can save lives, and that unclean water can carry disease-causing bacteria.

The overall health of a community is affected by social, cultural and economic factors. Health experts explore all aspects of people’s lives in order to fully expose and gauge the multitude of issues that impact community wellness. Public health practitioners are especially qualified as policy advocates and to promote behavioral change and wellness practices. While medical practitioners are interested in the health of individual patients, public health practitioners are interested in the health of the community as a whole. As former Surgeon General C. Everett Koop wrote, "health care is vital to all of us some of the time, but public health is vital to all of us all of the time." Reports in this category will include those aimed at pharmaceutical marketers and diagnostic marketers or those related to health statistics.

Public Health market research reports and industry analysis

Community-Acquired Infections – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... Community-Acquired Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Community-Acquired Infections. Community-Acquired Infections - Pipeline Review, Half Year is ... \| read more...	$2,000.00
The 2013-2018 World Outlook for Government Public Health Activities 1/7/2013 \| published by: Icon Group International, Inc. ... for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks ... \| read more...	$795.00
India Mosquito Nets Market Outlook to FY'2014 - Government Initiatives towards Universal Population Coverage through LLINs 1/1/2013 \| published by: Ken Research ... by product and geography of mosquito bed nets, free distribution of LLINs by the Government in India, market competition in terms of both domestic and foreign LLIN manufacturers. Mosquito nets are commonly referred to as ... \| read more...	$1,500.00
Public Health Partnering Terms and Agreements 1/1/2013 \| published by: Current Partnering ... the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest ... \| read more...	$2,695.00
Community Acquired Pneumonia – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... development for Community Acquired Pneumonia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Community Acquired Pneumonia. Community Acquired Pneumonia - ... \| read more...	$2,000.00
Getting Social With Disease: How Public Health Authorities in Central and Eastern Europe can Improve Outbreak Predictions with Social Media 12/11/2012 \| published by: IDC ... whether something "small" like an off-the-shelf analytics application or "large" like a full-scale migration of systems and software to a cloud-based delivery model. Usually this is okay. But in the realm of public health, it ... \| read more...	$1,500.00
Global Causes of Death to 2020 5/14/2012 \| published by: Espicom Healthcare Intelligence ... cause of death by 55 leading and emerging markets Evaluate at global and country level Rank cause of death globally and identify areas of increasing need Access original forecast data not in the public domain \| read more...	$2,265.00
Community-Acquired Infections - Pipeline Review, H1 2012 1/23/2012 \| published by: Global Markets Direct ... for Community-Acquired Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Community-Acquired Infections. 'Community-Acquired Infections - Pipeline Review, H1 2012' ... \| read more...	$500.00
Epidemiology: Hepatitis C in China – Epidemic yet to reach its peak 11/15/2011 \| published by: Datamonitor ... more than 40 million people are estimated to be infected with HCV, thereby presenting a huge single market potential for anti-HCV drugs. Introduction Gain insights into the estimates and forecast of prevalent HCV cases in ... \| read more...	$7,600.00
Comparative Guide to Health in America 7/1/2011 \| published by: Grey House Publishing Inc ... infant mortality to air quality, children in poverty to access to healthcare. This important new reference will offer a comprehensive look at the health of America, from the county level, with detailed profiles, ratings and ... \| read more...	$150.00
Epidemiology: Schizophrenia - Marginalized mental health disorder will continue to remain a public health burden 3/25/2011 \| published by: Datamonitor ... next 10 years. The highest increase in the number of cases will be in the US, with the majority of the seven major markets posting minor increases. Introduction Gain insight to market potential, including a ... \| read more...	$3,800.00
Epidemiology: Diabetes in China - Aging population, rising overweight and obesity are driving the diabetes epidemic 3/16/2011 \| published by: Datamonitor ... becoming an important chronic disease in China. In 2010, approximately 95 million people had diabetes by 2020 the number of diabetes cases will increase to 117 million. Introduction Gain insight to market potential, including a ... \| read more...	$5,700.00
Epidemiology: Hepatitis B in China - Hepatitis B will continue to remain a public health burden in China, despite a a projected decrease in prevalent cases 3/12/2011 \| published by: Datamonitor ... of hepatitis B in 2020. Introduction Gain insight into market potential, including a robust, 10-year epidemiology forecast of hepatitis B prevalent cases. Understand the key epidemiologic risk factors associated with hepatitis B in China. Highlights ... \| read more...	$5,700.00
The 2011-2016 World Outlook for Government Public Health Activities 1/20/2011 \| published by: Icon Group International, Inc. ... country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... \| read more...	$795.00
H1N1 (Swine Influenza) - Pipeline Review, Q4 2010 12/29/2010 \| published by: Global Markets Direct ... on the therapeutic development for H1N1 (Swine Influenza) Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for H1N1 (Swine Influenza) ... \| read more...	$500.00
Pricing and Reimbursement of Antivirals 6/1/2010 \| published by: Decision Resources ... treatments for both chronic and acute viral infections. Faced with growing expenditures on these medicines, governments and other payers are struggling to strike a balance between maintaining public health and preserving their finances. Based on ... \| read more...	$4,600.00
H1N1 "Swine Flu" Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines) 5/1/2010 \| published by: Kalorama Information ... manufacture and distribute a vaccine for the virus strain that may have had an impact in reducing cases and deaths. Who were the companies that performed best in this market? How did goverment contracts play ... \| read more...	$500.00
Special Report: The Pandemic Paradigm: Balancing Commercial Opportunities with Public Health Concerns in the Face of A/H1N1 2009 10/13/2009 \| published by: Decision Resources ... be warranted, given that no infectious disease has killed more people in a short period of time than influenza. Without preventive measures-such as vaccines-the current A/H1N1 ("swine flu") 2009 pandemic could claim more than 1 ... \| read more...	$9,200.00
Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact 8/6/2009 \| published by: Datamonitor ... and antivirals. The H1N1 pandemic will stimulate further growth, but also confronts industry and public health stakeholders with new challenges. Scope Strategic analysis of the current influenza market across the US, Japan, France, Germany, Italy, ... \| read more...	$15,200.00
Seasonal Influenza Vaccines Market Forecast 8/6/2009 \| published by: Datamonitor ... and antivirals. The H1N1 pandemic will stimulate further growth, but also confronts industry and public health stakeholders with new challenges. Reasons to Purchase Review the clinical and commercial factors driving new product decisions in influenza ... \| read more...	$15,200.00
The Global Influenza Market 8/1/2009 \| published by: BCC Research ... the segments of vaccines/therapeutics and diagnostics. Each market segment discussion provides detailed information based on product categories, use of products, forecasts, and competitive analysis Covers some of the most significant issues, trends and market factors ... \| read more...	$5,450.00
Eclipsys: An HIT First Responder with H1N1 Influenza Toolkit 5/18/2009 \| published by: IDC ... United States, Eclipsys released an influenza A H1N1 (swine flu) outcomes toolkit that is designed to help hospitals using its electronic medical record (EMR) to limit the spread of influenza in hospital waiting areas. It ... \| read more...	$1,500.00
MarketVIEW: H1N1 vaccine (US demand model) 5/1/2009 \| published by: VacZine Analytics ... infection with over half of the cases being identified in the continental United States. Using currently available information regarding the expected profile, possible allocation of H1N1 specific vaccine and predictions of pandemic severity, VacZine Analytics ... \| read more...	$1,995.00
H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) 5/1/2009 \| published by: Kalorama Information ... appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both ... \| read more...	$250.00
The 2009 Report on Government Public Health Activities: World Market Segmentation by City 5/1/2009 \| published by: Icon Group International, Inc. ... as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major ... \| read more...	$795.00

< prev 1 2 next >